A study about drug combination therapy of Schisandra sphenanthera extract and Rapamycin in healthy subjects

To assess the effect of the drug combination of Schisandra sphenanthera extract (SchE) and Rapamycin (RAPA), 18 healthy subjects were given oral treatments of RAPA alone and with SchE. Pharmacokinetic investigations and indexes of hepatic and renal functions, as well as other indices of oral RAPA ad...

Full description

Saved in:
Bibliographic Details
Published inCanadian journal of physiology and pharmacology Vol. 90; no. 7; pp. 941 - 945
Main Authors Li, Ruidong, Guo, Wenyuan, Fu, Zhiren, Ding, Guoshan, Wang, Zhengxin, Fu, Hong
Format Journal Article
LanguageEnglish
Published Plattsburgh, NY NRC Research Press 01.07.2012
National Research Council of Canada
Canadian Science Publishing NRC Research Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To assess the effect of the drug combination of Schisandra sphenanthera extract (SchE) and Rapamycin (RAPA), 18 healthy subjects were given oral treatments of RAPA alone and with SchE. Pharmacokinetic investigations and indexes of hepatic and renal functions, as well as other indices of oral RAPA administration (2 mg), were performed both before and after the SchE treatment period. Whole-blood RAPA concentrations were determined by enzyme-linked immunosorbent assay. The research found that the mean whole-blood RAPA AUC 0–∞ , C max , and t max increased almost 2-, 2.1-, and 1.3-fold, respectively, and CL/F (–38.0%) decreased almost 1.6-fold in these subjects when RAPA was administered with SchE compared with oral RAPA administered alone. The results of this study proved that SchE can increase the oral bioavailability of RAPA and will add important information to the interaction area between drugs and herbal products.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0008-4212
1205-7541
1205-7541
DOI:10.1139/y2012-080